logo
Frasers Property makes second bid to privatise Frasers Hospitality Trust in $1.37 billion deal

Frasers Property makes second bid to privatise Frasers Hospitality Trust in $1.37 billion deal

Straits Times14-05-2025

FHT has a portfolio of 14 hotels and serviced residences across nine cities in Asia, Australia and Europe. It includes InterContinental Singapore (pictured. PHOTO: LIANHE ZAOBAO
SINGAPORE - Thai billionaire Charoen Sirivadhanabhakdi's Frasers Property is making a second attempt to take private its hospitality real-estate investment trust at a valuation of $1.37 billion.
The company on May 14 announced an offer of 71 cents per share for Frasers Hospitality Trust (FHT).
This represents a 7 per cent premium to FHT's last traded price of 66.5 cents before the counter announced a trading halt on May 13. It is also a 36.3 per cent premium to the FHT's volume weighted average price for the 12-month period up to the last trading date.
Frasers Property owns a 24.23 per cent stake in FHT, while its majority shareholder and Mr Charoen's family conglomerate TCC Assets has a 36.72 per cent stake.
An attempted privatization in 2022 at 70 cents a share - which valued FHT then at $1.35 billion - failed when it fell short of a 75 per cent shareholder threshold required.
The latest offer to take the trust private is the outcome of a strategic review conducted by the directors of the trust after they evaluated various options, both companies said in a joint statement.
They cited challenges due to the changing macroeconomic environment, such as a weaker foreign exchange rate against the Singapore dollar, higher interest rate environment, global cost inflation and unforeseen events such as Brexit and the Covid-19 pandemic.
'The directors view the privatisation as a viable option for stapled securityholders to immediately realise their investment at a premium to net asset value and offers strong deal certainty in terms of timing and execution,' they said.
'Frasers Hospitality Trust is expected to continue to face both macroeconomic headwinds and structural limitations which may limit its ability to grow its distribution per stapled security and net asset value,' they added.
The hospitality trust's smaller size relative to its peers has also contributed to a higher cost of equity and lower debt headroom which limits its ability to scale up, they said.
Its properties are also located in areas where the currencies have depreciated significantly - by 20 per cent to 30 per cent - against the Singapore dollar since its listing, they noted.
FHT has a portfolio of 14 hotels and serviced residences across nine cities in Asia, Australia and Europe. The properties include InterContinental Singapore, Fraser Suites Sydney and Park International London.
Listed on the SGX mainboard since 2014, FHT has a market capitalisation of $1.27 billion, with a portfolio valued at $2 billion as of Sept 2024.
The trust's managers chief executive officer Eric Gan said: 'The decision to propose this scheme was not taken lightly.
The scheme will require the necessary regulatory and court approvals, and is subject to the approval of a majority of its stapled securityholders.
Frasers Property group chief financial officer Loo Choo Leong said the group's strategy is focused on delivering sustainable and targeted long-term returns across cycles.
'Hospitality is a core business for Frasers Property, and while we remain mindful of near-term challenges facing the hospitality sector, we maintain a long-term investment perspective,' he said.
Frasers Property, which also called for a trading halt on May 13, has total assets of approximately $38.9 billion as at March 31.
It operates across commercial and business parks, hospitality, industrial and logistics, residential and retail, with businesses in South-east Asia, Australia, Europe, Britain and China.
It also owns or operates serviced apartments and hotels in 20 countries across Asia, Australia, Europe, the Middle East and Africa.
Sue-Ann Tan is a business correspondent at The Straits Times covering capital markets and sustainable finance.
Join ST's Telegram channel and get the latest breaking news delivered to you.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Singapore Paincare up 12.1% as Sias urges shareholders to await IFA report
Singapore Paincare up 12.1% as Sias urges shareholders to await IFA report

Business Times

time8 hours ago

  • Business Times

Singapore Paincare up 12.1% as Sias urges shareholders to await IFA report

[SINGAPORE] Shares of Singapore Paincare rose on Thursday (Jun 5), a day after the Securities Investors Association (Singapore), or Sias, said the medical services company could be worth more than double its privatisation offer price. As at 4.19 pm, the counter was trading at S$0.176, 12.1 per cent or S$0.019 above the previous closing price of S$0.157 on Wednesday, with 15.2 million shares transacted. This was its highest price in the year to date. It closed on Thursday 8.3 per cent or S$0.013 higher at S$0.17, with 17.3 million shares having changed hands. On Wednesday, Sias urged minority shareholders of Singapore Paincare to hold off selling their shares amid an acquisition bid from Advance Bridge Healthcare, a management consultancy for healthcare services. Sias noted that the company could be worth around S$0.36 to S$0.37 a share, more than double the S$0.16 a share privatisation offer price. It recommended that shareholders wait and refrain from taking action until the report by the independent financial adviser (IFA) is released. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up 'If the shares are sold on the open market, shareholders who sold will not have recourse if there is subsequent upward revision in the offer price,' Sias warned. There have been past instances when shareholders sought slight gains and sold their shares on the open market before the IFA issued its report, it noted. Moreover, the S$0.37 per share offer price is at a 'slight discount' to the company's audited net asset value (NAV) per share of S$0.166 as at Jun 30, 2024, it said. The association highlighted that Singapore Paincare made its July 2020 trading debut during Covid-19 with an initial public offering (IPO) price of S$0.22 per share, when valuations were depressed and when the Straits Times Index (STI) was trading at around 2,500 points. The IPO price of S$0.22 was a 123 per cent premium to the group's unaudited NAV per share of about S$0.0986 on Dec 31, 2019, based on the post-placement share capital and after adjusting for net proceeds due to the company from the placement. 'It now wishes to delist at S$0.16 per share when the STI is trading at around 3,900 points... If the same IPO premium were to be applied now, the privatisation price should be around S$0.36 to S$0.37,' Sias said. 'For a delisting to take place, the IFA has to conclude that the offer is both fair and reasonable... it would therefore be advisable to wait for the IFA's opinion.'

Singapore Paincare up 12.1% on Sias valuation
Singapore Paincare up 12.1% on Sias valuation

Business Times

time9 hours ago

  • Business Times

Singapore Paincare up 12.1% on Sias valuation

[SINGAPORE] Shares of Singapore Paincare rose on Thursday (Jun 5), a day after the Securities Investors Association (Singapore), or Sias, valued the medical services company at more than double its privatisation offer price. As at 4.19 pm, the counter was trading at S$0.176, 12.1 per cent or S$0.019 above the previous closing price of S$0.157 on Wednesday, with 15.2 million shares transacted. This was its highest price in the year to date. It closed on Thursday 8.3 per cent or S$0.013 higher at S$0.17, with 17.3 million shares having changed hands. On Wednesday, Sias urged minority shareholders of Singapore Paincare to hold off selling their shares amid an acquisition bid from Advance Bridge Healthcare, a management consultancy for healthcare services. Sias noted that the company could be worth S$0.37 a share, more than double the S$0.16 a share privatisation offer price. It recommended that shareholders wait and refrain from taking action until the report by the independent financial adviser (IFA) is released. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up 'If the shares are sold on the open market, shareholders who sold will not have recourse if there is subsequent upward revision in the offer price,' Sias warned. There have been past instances when shareholders sought slight gains and sold their shares on the open market before the IFA issued its report, it noted. Moreover, the S$0.37 per share offer price is at a 'slight discount' to the company's audited net asset value (NAV) per share of S$0.166 as at Jun 30, 2024, it said. The association highlighted that Singapore Paincare made its July 2020 trading debut during Covid-19 with an initial public offering (IPO) price of S$0.22 per share, when valuations were depressed and when the Straits Times Index (STI) was trading at around 2,500 points. The IPO price of S$0.22 was a 123 per cent premium to the group's unaudited NAV per share of about S$0.0986 on Dec 31, 2019, based on the post-placement share capital and after adjusting for net proceeds due to the company from the placement. 'It now wishes to delist at S$0.16 per share when the STI is trading at around 3,900 points... If the same IPO premium were to be applied now, the privatisation price should be around S$0.36 to S$0.37,' Sias said. 'For a delisting to take place, the IFA has to conclude that the offer is both fair and reasonable... it would therefore be advisable to wait for the IFA's opinion.'

Nintendo Switch 2 launches globally with shortages expected amid pent-up demand
Nintendo Switch 2 launches globally with shortages expected amid pent-up demand

New Paper

time14 hours ago

  • New Paper

Nintendo Switch 2 launches globally with shortages expected amid pent-up demand

Nintendo's Switch 2 launched on June 5 and is widely expected to be in short supply globally amid pent-up demand for the more powerful next-generation gaming device. "The level of demand seems to be sky-high," said Mr Serkan Toto, founder of the Kantan Games consultancy. The Switch launched in 2017 and followed the underperforming Wii U. The home-portable device became a juggernaut with games including two The Legend Of Zelda titles and Covid-19 pandemic breakout hit Animal Crossing: New Horizons. The Switch 2 bears many similarities with its predecessor but offers a larger screen and improved graphics and debuts with titles including Mario Kart World. "The much larger audience of Switch users should translate to stronger adoption in the opening part of its life-cycle," said Mr Piers Harding-Rolls, an analyst at Ampere Analysis. "Nintendo is better prepared this time around" to deal with the high demand, he said. The launch of the US$499.99 (S$643) Switch 2 is a test of Nintendo's supply chain management during United States President Donald Trump's trade war. Nintendo in May forecast sales of 15 million Switch 2 units during the current financial year. President Shuntaro Furukawa said Nintendo will strengthen production capacity to respond to strong demand and focus on sales promotion in an effort to exceed the forecast. The company, which is known for conservative forecasts, also expects to sell 4.5 million Switch units. A staff member at an electronics store in Tokyo holds a megaphone on June 5, the day Nintendo starts selling the Nintendo Switch 2 game console globally. PHOTO: REUTERS Nintendo said it received 2.2 million applications for its Switch 2 sales lottery on its official site My Nintendo Store in Japan. Pre-orders at Target sold out in less than two hours. "You are looking at weeks or months until you can walk into a store and buy a Switch 2," said Mr Toto of Kantan Games. Investor expectations for the new device are similarly lofty. Nintendo's shares are trading near highs and have gained almost 30 per cent in 2025. Concerns include whether momentum for the Switch 2 will be sustained after hardcore gamers have upgraded. "The volume of first-party games on offer at launch isn't as strong as it could be, so some more casual users may wait and see how the games available build over the next one to two years before making the leap," said Ampere's Mr Harding-Rolls. Ampere forecasts Switch 2 sales to exceed 100 million units in 2030. Nintendo has sold 152 million Switch units in total.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store